LewisJ. J., and Van PettenG. R.: Brit. J. Pharmacol.20, 462(1963).
18.
MaxwellD. R., GrayW. R., and TaylorE. M.: Brit. J. Pharmacol.17, 310 (1961).
19.
MurphyG. F., and SourkesT. L.: Arch. Biochem. Biophys.93, 338(1961).
20.
PoirierL., and SourkesT. L.: Brain88, 181(1965).
21.
PscheidtG. R.: Ann. N. Y. Acad. Sci.107, 1057(1963).
22.
RensonJ., WeissbachH., and UdenfriendS.: J. Pharmacol. Exp. Therap.143, 326(1964).
23.
SanoI., TaniguchiK., GamoT., TakesadaM., and KakimotoY.: Klin. Wochschr.38, 57(1960).
24.
SeverinaI. S., and GorkinV. Z.: Biokhimiya28, 896(1963).
25.
SourkesT. L.: Rev. Canad. de Biol.17, 328(1958).
26.
SourkesT. L.: In Biochemical and Neurophysiological Correlation of Centrally Acting Drugs, Proc. 2nd Intern. Pharmacol. Meet., Prague, 1963.Oxford, Pergamon Press, 1964. (p. 35–50).
27.
SourkesT. L., and PoirierL.: Nature (London)207, 202(1965).
28.
WightmanK. J. R. (chairman): Report of a Special Committee on Tranylcypromine and Other Amine-Oxidase Inhibitors.Ottawa, Department of National Health and Welfare, 1964.
29.
WisemanM. H., and SourkesT. L.: Biochem. J.78, 123(1961).
30.
Wiseman-DistlerM. H., and SourkesT. L.: Canad. J. Biochem. Physiol.41, 57(1963).
31.
YoudimM. B. H., and SourkesT. L.: Canad. J. Biochem. Physiol.43, 1305(1965).